Back to search

Ireland· IE-PA-PA2219/002/001

LG-octaplas, solution for infusion

A blood substitutes and plasma protein fractions product containing human plasma protein, registered in Ireland by Octapharma (IP). The same ATC class is registered in 7 of our 19 countries.

ATC B05AA

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedLG-octaplas, solution for infusionATCB05AAREGISTER NO.IE-PA-PA2219/002/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Human plasma protein is registered in 7 of 19 countries.

Countries holding a registration under ATC B05AA (blood substitutes and plasma protein fractions), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 4 of them publish a price we can compare per daily dose

Human plasma protein · ATC B05AA

7 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Human plasma protein
Manufacturer
Octapharma (IP)
Country
Ireland (IE)
ATC code
B05AA
ATC class
Blood substitutes and plasma protein fractions
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA2219/002/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Human plasma protein in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All human plasma protein products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Albunorm, Alburex
  • Belgium · Alburex, Human Albumin Csl Behring
  • Bulgaria · Албурекс, Октапласlg
  • Cyprus · Albumeon, Alburex
  • Czechia · Alburex, Human Albumin Csl Behring
  • Germany · Albumeon, Albunorm
  • Denmark · Albumin Behring, Albunorm
  • Estonia · Human Albumin Csl Behring, Octaplaslg
  • Spain · Albúmina Humana Csl Behring, Albunorm
  • Finland · Albumin Behring, Albunorm
  • France · Albumine Humaine Csl Behring, Albunorm
  • United Kingdom (Northern Ireland) · Albumeon, Alburex
  • Greece · Albumeon, Alburex
  • Croatia · Albumeon, Albunorm
  • Hungary · Alburex, Human Albumin Csl Behring
  • Iceland · Albumin Behring, Albunorm
  • Italy · Albumeon, Albunorm
  • Lithuania · Human Albumin Csl Behring, Octaplasma
  • Luxembourg · Alburex, Human Albumin Csl Behring
  • Latvia · Human Albumin Csl Behring, Octaplasma
  • Malta · Albumeon, Alburex
  • Netherlands · Albunorm, Alburex
  • Norway · Albumin Behring, Albunorm
  • Poland · Alburex, Human Albumin Csl Behring
  • Portugal · Albumina Humana Csl Behring, Alburex
  • Romania · Albumeon, Alburex
  • Sweden · Albumin Behring, Albunorm
  • Slovenia · Alburex, Humani Albumin Csl Behring
  • Slovakia · Alburex, Human Albumin Csl Behring

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/057a2885-c034-4fff-89ba-f70450ef960e
GET /v1/drugs/057a2885-c034-4fff-89ba-f70450ef960e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "B05AA"
  ],
  "strength": null,
  "pa_number": "PA2219/002/001",
  "substances": [
    "Human plasma protein"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "09/03/2001",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about human plasma protein.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.